Oscar Health Inc’s recent filing unveils that its Former Officer ALESSANDREA QUANE acquired Company’s shares for reported $84181.0 on Mar 07 ’25. In the deal valued at $16.50 per share,5,101 shares were bought.
Then, ALESSANDREA QUANE bought 20,000 shares, generating $325,654 in total proceeds.
Before that, STEVEN WOLIN bought 167,466 shares. Oscar Health Inc shares valued at $2,519,576 were divested by the Former Affiliate at a price of $15.05 per share.
Jefferies initiated its Oscar Health Inc [OSCR] rating to an Underperform in a research note published on December 10, 2024; the price target was $12. A number of analysts have revised their coverage, including BofA Securities’s analysts, who decreased its forecast for the stock in early November from “a Neutral” to “an Underperform”. UBS began covering OSCR with “Neutral” recommendation on October 07, 2024. Piper Sandler started covering the stock on June 26, 2024. It rated OSCR as “an Overweight”.
Price Performance Review of OSCR
On Friday, Oscar Health Inc [NYSE:OSCR] saw its stock jump 2.18% to $15.96. Over the last five days, the stock has gained 9.24%. Oscar Health Inc shares have risen nearly 18.75% since the year began. Nevertheless, the stocks have risen 14.74% over the past one year. While a 52-week high of $23.79 was reached on 01/24/25, a 52-week low of $12.43 was recorded on 02/13/25. SMA at 50 days reached $15.11, while 200 days put it at $17.01.
Levels Of Support And Resistance For OSCR Stock
The 24-hour chart illustrates a support level at 15.43, which if violated will result in even more drops to 14.91. On the upside, there is a resistance level at 16.52. A further resistance level may holdings at 17.09. The Relative Strength Index (RSI) on the 14-day chart is 54.58, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.44, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 32.06%. Stochastics %K at 73.09% indicates the stock is a holding.
The most recent change occurred on May 30, 2024 when Robert W. Baird began covering the stock and recommended ‘”an Outperform”‘ rating along with a $28 price target.
